BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34740480)

  • 1. Early age of onset is an independent predictor for worse disease-free survival in sporadic rectal cancer patients. A comparative analysis of 980 consecutive patients.
    Foppa C; Tamburello S; Maroli A; Carvello M; Poliani L; Laghi L; Malesci A; Montorsi M; Perea J; Spinelli A
    Eur J Surg Oncol; 2022 Apr; 48(4):857-863. PubMed ID: 34740480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Age of Onset Is an Independent Predictor for a Worse Response to Neoadjuvant Therapies in Sporadic Rectal Cancer Patients.
    Foppa C; Maroli A; Luberto A; La Raja C; Spaggiari P; Bonifacio C; De Zanet S; Montorsi M; Piscuoglio S; Terracciano LM; Santoro A; Spinelli A
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant radiation above NCCN guidelines for rectal cancer is associated with age under 50 and early clinical stage.
    Bliggenstorfer JT; Bingmer K; Ofshteyn A; Stein SL; Charles R; Steinhagen E
    Surg Endosc; 2022 May; 36(5):2925-2935. PubMed ID: 34114070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
    Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
    BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Perirectal Fat in the Carcinogenesis and Development of Early-Onset Rectal Cancer.
    Pan AF; Zheng NX; Wang J; Kabemba JLT; Zheng K; Shen F; Zhang W; Gao XH
    J Oncol; 2022; 2022():4061142. PubMed ID: 35368890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
    Evers PD; Logan JE; Sills V; Chin AI
    World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Intersphincteric Resection With Coloanal Anastomosis for Locally Advanced Low Rectal Cancer.
    Park JS; Park SY; Kim HJ; Cho SH; Kwak SG; Choi GS
    Dis Colon Rectum; 2019 Apr; 62(4):408-416. PubMed ID: 30688680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different Oncologic Outcomes in Early-Onset and Late-Onset Sporadic Colorectal Cancer: A Regression Analysis on 2073 Patients.
    Foppa C; Maroli A; Lauricella S; Luberto A; La Raja C; Bunino F; Carvello M; Sacchi M; De Lucia F; Clerico G; Montorsi M; Spinelli A
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Young colorectal carcinoma patients do not have a poorer prognosis: a comparative review of 2,426 cases.
    Yeo SA; Chew MH; Koh PK; Tang CL
    Tech Coloproctol; 2013 Dec; 17(6):653-61. PubMed ID: 23460362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery.
    Derbel O; Wang Q; Desseigne F; Rivoire M; Meeus P; Peyrat P; Stella M; Martel-Lafay I; Lemaistre AI; de La Fouchardière C
    BMC Cancer; 2013 Apr; 13():200. PubMed ID: 23617638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships among
    Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
    World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic and survival outcomes in elderly patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy and total mesorectal excision.
    He F; Chen M; Xiao WW; Zhang Q; Liu Y; Zheng J; Wan XB; Gao YH
    Jpn J Clin Oncol; 2021 Aug; 51(9):1391-1399. PubMed ID: 34155513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
    Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
    Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of progression-free survival for locally advanced rectal cancer by MRI after neoadjuvant chemoradiotherapy and total mesorectal excision].
    Zhang JX; Yang Z; Fan P; Zhang JJ; Xin L; Hou LN; Du XS; Yang XT
    Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):121-126. PubMed ID: 29502372
    [No Abstract]   [Full Text] [Related]  

  • 16. Does IBD Portend Worse Outcomes in Patients with Rectal Cancer? A Case-Matched Analysis.
    Alsughayer A; Grass F; McKenna NP; Petersen M; Mathis KL; Lightner AL
    Dis Colon Rectum; 2020 Sep; 63(9):1265-1275. PubMed ID: 33216497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retrospective analysis of 856 cases with stage 0 to III rectal cancer underwent curative surgery combined modality therapy].
    Chen P; Yao Y; Zhao J; Li M; Peng Y; Zhan T; Du C; Wang L; Chen N; Gu J
    Zhonghua Wai Ke Za Zhi; 2015 Jul; 53(7):496-501. PubMed ID: 26359071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
    Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
    Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy.
    Huebner M; Wolff BG; Smyrk TC; Aakre J; Larson DW
    World J Surg; 2012 Mar; 36(3):675-83. PubMed ID: 22270980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Joint Committee on Cancer and College of American Pathologists regression grade: a new prognostic factor in rectal cancer.
    Mace AG; Pai RK; Stocchi L; Kalady MF
    Dis Colon Rectum; 2015 Jan; 58(1):32-44. PubMed ID: 25489692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.